Literature DB >> 2201645

Characterization of Tritrichomonas foetus antigens by use of monoclonal antibodies.

J L Hodgson1, D W Jones, P R Widders, L B Corbeil.   

Abstract

The specificity for and function of monoclonal antibodies against Tritrichomonas foetus were characterized. Four monoclonal antibodies generated by immunization of mice with live T. foetus were selected on the basis of enzyme-linked immunosorbent assay reactions. The approximate molecular masses of the predominant proteins were determined by Western blotting (immunoblotting). Monoclonal antibody TF3.8 recognized a predominant band at approximately 155 kilodaltons, whereas TF3.2 reacted with several bands. Monoclonal antibodies TF1.17 and TF1.15 recognized broad bands between 45 and 75 kilodaltons. The first two antibodies (TF3.8 and TF3.2) did not react with the surface of T. foetus, as determined by live-cell immunofluorescence, agglutination, and immobilization, whereas two other monoclonal antibodies (TF1.17 and TF1.15) did react with surface epitopes, as determined by these criteria. The latter two monoclonal antibodies also mediated complement-dependent killing of T. foetus and prevented of adherence of organisms to bovine vaginal epithelial cells. One antibody, TF1.15, also killed in the absence of complement. Since these functions are in vitro correlates of protection, the antigens recognized by these monoclonal antibodies may induce protective immunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201645      PMCID: PMC313614          DOI: 10.1128/iai.58.9.3078-3083.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Early pathogenesis and pathology of Tritrichomonas foetus infection in virgin heifers.

Authors:  I M Parsonson; B L Clark; J H Dufty
Journal:  J Comp Pathol       Date:  1976-01       Impact factor: 1.311

3.  Investigations of the incidence of bovine trichomoniasis in nevada and of the efficacy of immunizing cattle with vaccines containing Tritrichomonas foetus.

Authors:  W G Kvasnicka; R E Taylor; J C Huang; D Hanks; R J Tronstad; A Bosomworth; M R Hall
Journal:  Theriogenology       Date:  1989-05       Impact factor: 2.740

4.  Tritrichomonas foetus: preparation of monoclonal antibodies with effector function.

Authors:  D E Burgess
Journal:  Exp Parasitol       Date:  1986-10       Impact factor: 2.011

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Characterization of Tritrichomonas foetus antigens, using bovine antiserum.

Authors:  M R Hall; J C Huang; R Ota; D Redelman; D Hanks; R E Taylor
Journal:  Am J Vet Res       Date:  1986-12       Impact factor: 1.156

7.  Adherence of Tritrichomonas foetus to bovine vaginal epithelial cells.

Authors:  L B Corbeil; J L Hodgson; D W Jones; R R Corbeil; P R Widders; L R Stephens
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

8.  Activation of the alternative complement pathway by Trichomonas vaginalis.

Authors:  F D Gillin; A Sher
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

9.  Trichomonas vaginalis: alternative pathway activation of complement.

Authors:  T W Holbrook; R J Boackle; J Vesely; B W Parker
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

10.  Impact of trichomoniasis on the cow-calf producer's profitability.

Authors:  D O Rae
Journal:  J Am Vet Med Assoc       Date:  1989-03-15       Impact factor: 1.936

View more
  15 in total

Review 1.  Comparative aspects of immunity and vaccination in human and bovine trichomoniasis: a review.

Authors:  Aspinas Chapwanya; Abubakar Yusha'u Usman; Pete Charles Irons
Journal:  Trop Anim Health Prod       Date:  2015-09-30       Impact factor: 1.559

2.  Bovine IgG2a antibodies to Haemophilus somnus and allotype expression.

Authors:  L B Corbeil; R P Gogolewski; I Kacskovics; K H Nielsen; R R Corbeil; J L Morrill; R Greenwood; J E Butler
Journal:  Can J Vet Res       Date:  1997-07       Impact factor: 1.310

3.  Murine models of vaginal trichomonad infections.

Authors:  Eduardo R Cobo; Lars Eckmann; Lynette B Corbeil
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

4.  Adhesion of Tritrichomonas foetus to bovine vaginal epithelial cells.

Authors:  B N Singh; J J Lucas; D H Beach; S T Shin; R O Gilbert
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  PCR-based study of conserved and variable DNA sequences of Tritrichomonas foetus isolates from Saskatchewan, Canada.

Authors:  D E Riley; B Wagner; L Polley; J N Krieger
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Conservation of a protective surface antigen of Tritrichomonas foetus.

Authors:  J S Ikeda; R H BonDurant; C M Campero; L B Corbeil
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  Immunoglobulin binding by Tritrichomonas foetus.

Authors:  L B Corbeil; J L Hodgson; P R Widders
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

8.  Immunization of virgin cows with surface antigen TF1.17 of Tritrichomonas foetus.

Authors:  R H BonDurant; R R Corbeil; L B Corbeil
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  Analysis of adhesion and cytotoxicity of Tritrichomonas foetus to mammalian cells by use of monoclonal antibodies.

Authors:  D E Burgess; C M McDonald
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Bovine vaginal antibody responses to immunoaffinity-purified surface antigen of Tritrichomonas foetus.

Authors:  J S Ikeda; R H BonDurant; L B Corbeil
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.